Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
$1.39M
13 trades · 4 insiders
Net · 90d
$-1.39M
Insiders on file
28
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Hansen Gwenn | Chief Scientific Officer | 211 | $0 | $1.96M | 2026-11-02 |
| van Houte Hans | Chief Financial Officer | 173 | $0 | $4.88M | 2026-10-30 |
| Ring Christine | General Counsel | 286 | $0 | $6.83M | 2026-10-30 |
| GREGORY JULIA P | Director | 11 | $0 | $528.5K | 2026-10-14 |
| Saltzman Edward C | Director | 5 | $0 | $0 | 2026-05-15 |
| DANSEY ROGER D | Director | 2 | $0 | $0 | 2026-05-15 |
| Lacey David L. | Director | 6 | $0 | $0 | 2026-05-15 |
| Kapur Anil | Director | 3 | $0 | $0 | 2026-05-15 |
| Baynes Roy D. | Director | 3 | $0 | $0 | 2026-05-15 |
| Silva Paul M | Director | 6 | $0 | $0 | 2026-05-15 |
| Reinsdorf Judith A | Director | 6 | $0 | $0 | 2026-05-15 |
| SANDS ARTHUR T | President, CEO | 8 | $0 | $0 | 2026-02-10 |
| Kunkel Lori Anne | Director | 6 | $0 | $0 | 2025-05-19 |
| Wolff Stefani | EVP and COO | 20 | $0 | $22.3K | 2023-05-01 |
| SIEGALL CLAY B | Director | 2 | $0 | $0 | 2022-05-05 |
| Beaurang Pierre | Chief Business Officer | 44 | $0 | $1.84M | 2021-08-10 |
| Chen Leon | Director | 1 | $0 | $0 | 2021-05-06 |
| Third Rock Ventures GP III, L.P. | 10% Owner | 1 | $0 | $0 | 2021-05-06 |
| Tong Jeffrey K | Director, 10% Owner | 1 | $0 | $0 | 2021-05-06 |
| Ponoi Management, LLC | 10% Owner | 15 | $0 | $0 | 2021-05-05 |
| Svennilson Peter | 10% Owner | 15 | $0 | $0 | 2021-05-05 |
| Third Rock Ventures III, L.P. | 10% Owner | 1 | $0 | $0 | 2021-02-04 |
| Tjian Robert | Director | 4 | $0 | $0 | 2020-07-28 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | 10% Owner | 2 | $0 | $0 | 2020-07-28 |
| Ponoi II Management, LLC | 10% Owner | 12 | $0 | $0 | 2020-07-28 |
| Green Jeremy | 10% Owner | 2 | $0 | $0 | 2020-07-28 |
| COLUMN GROUP L P | 10% Owner | 12 | $0 | $0 | 2020-07-28 |
| LEVIN MARK J | 10% Owner | 6 | $0 | $0 | 2020-07-28 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-11-02 | 2026-11-02 | 1,452 | — | $0 | 57,954 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-11-02 | 2026-11-02 | 1,452 | $26.80 | $38.9K | 123,452 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-11-02 | 2026-11-02 | 1,452 | $1.86 | $2.7K | 124,904 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 3,573 | — | $0 | 35,730 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 2,859 | — | $0 | 17,150 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 3,750 | — | $0 | 7,500 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-10-30 | 2026-11-02 | 3,957 | $26.28 | $104.0K | 15,335 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-10-30 | 2026-11-02 | 3,573 | — | $0 | 19,292 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-10-30 | 2026-11-02 | 2,859 | — | $0 | 15,719 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-10-30 | 2026-11-02 | 3,750 | — | $0 | 12,860 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 3,573 | — | $0 | 35,730 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 2,859 | — | $0 | 17,150 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 3,750 | — | $0 | 7,500 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-10-30 | 2026-11-02 | 2,834 | $26.28 | $74.5K | 47,514 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-10-30 | 2026-11-02 | 3,573 | — | $0 | 50,348 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-10-30 | 2026-11-02 | 2,859 | — | $0 | 46,775 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-10-30 | 2026-11-02 | 3,750 | — | $0 | 43,916 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 3,573 | — | $0 | 35,730 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 2,859 | — | $0 | 17,150 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-10-30 | 2026-11-02 | 3,750 | — | $0 | 7,500 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-10-30 | 2026-11-02 | 3,957 | $26.28 | $104.0K | 123,452 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-10-30 | 2026-11-02 | 3,573 | — | $0 | 127,409 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-10-30 | 2026-11-02 | 2,859 | — | $0 | 123,836 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-10-30 | 2026-11-02 | 3,750 | — | $0 | 120,977 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-10-15 | 2026-10-15 | 1,452 | — | $0 | 59,406 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-10-15 | 2026-10-15 | 1,452 | $25.00 | $36.3K | 117,227 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-10-15 | 2026-10-15 | 1,452 | $1.86 | $2.7K | 118,679 | SEC↗ |
| GREGORY JULIA P | Director | M Exercise deriv | 2026-10-14 | 2026-10-14 | 22,583 | — | $0 | 0 | SEC↗ |
| GREGORY JULIA P | Director | S Sale | 2026-10-14 | 2026-10-14 | 22,583 | $23.40 | $528.5K | 10,750 | SEC↗ |
| GREGORY JULIA P | Director | M Exercise | 2026-10-14 | 2026-10-14 | 22,583 | $1.86 | $42.0K | 33,333 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-10-02 | 2026-10-02 | 5,786 | — | $0 | 111,251 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-10-02 | 2026-10-02 | 5,786 | $23.19 | $134.1K | 9,110 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-10-02 | 2026-10-02 | 5,786 | $8.72 | $50.5K | 14,896 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-09-02 | 2026-09-02 | 5,787 | — | $0 | 117,037 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-09-02 | 2026-09-02 | 5,387 | $25.69 | $138.4K | 9,510 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-09-02 | 2026-09-02 | 400 | $26.64 | $10.7K | 9,110 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-09-02 | 2026-09-02 | 5,787 | $8.72 | $50.5K | 14,897 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-09-02 | 2026-09-02 | 5,787 | — | $0 | 117,037 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-09-02 | 2026-09-02 | 400 | $26.64 | $10.7K | 9,110 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-09-02 | 2026-09-02 | 5,387 | $25.69 | $138.4K | 9,510 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-09-02 | 2026-09-02 | 5,787 | $8.72 | $50.5K | 14,897 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-09-01 | 2026-09-01 | 1,452 | — | $0 | 60,858 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-09-01 | 2026-09-01 | 1,452 | $1.86 | $2.7K | 118,679 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-09-01 | 2026-09-01 | 1,452 | $25.47 | $37.0K | 117,227 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-09-01 | 2026-09-01 | 1,452 | — | $0 | 60,858 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-09-01 | 2026-09-01 | 1,452 | $25.47 | $37.0K | 117,227 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-09-01 | 2026-09-01 | 1,452 | $1.86 | $2.7K | 118,679 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-08-05 | 2026-08-05 | 4,356 | — | $0 | 62,310 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-08-05 | 2026-08-05 | 4,356 | $1.86 | $8.1K | 121,583 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-08-05 | 2026-08-05 | 4,356 | $25.00 | $108.9K | 117,227 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-08-05 | 2026-08-05 | 4,356 | — | $0 | 62,310 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-08-05 | 2026-08-05 | 4,356 | $25.00 | $108.9K | 117,227 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-08-05 | 2026-08-05 | 4,356 | $1.86 | $8.1K | 121,583 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-08-04 | 2026-08-04 | 2,967 | $24.65 | $73.1K | 40,166 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-08-04 | 2026-08-04 | 1,794 | $23.89 | $42.9K | 43,133 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-08-04 | 2026-08-05 | 1,500 | $23.87 | $35.8K | 119,838 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-08-04 | 2026-08-05 | 2,611 | $24.64 | $64.3K | 117,227 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-08-04 | 2026-08-04 | 2,967 | $24.65 | $73.1K | 40,166 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-08-04 | 2026-08-04 | 1,794 | $23.89 | $42.9K | 43,133 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-08-04 | 2026-08-05 | 2,611 | $24.64 | $64.3K | 117,227 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-08-04 | 2026-08-05 | 1,500 | $23.87 | $35.8K | 119,838 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-08-03 | 2026-08-03 | 5,787 | — | $0 | 122,824 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-08-03 | 2026-08-03 | 5,787 | $8.72 | $50.5K | 25,699 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-08-03 | 2026-08-03 | 16,589 | $23.05 | $382.4K | 9,110 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-08-03 | 2026-08-03 | 5,787 | — | $0 | 122,824 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-08-03 | 2026-08-03 | 16,589 | $23.05 | $382.4K | 9,110 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-08-03 | 2026-08-03 | 5,787 | $8.72 | $50.5K | 25,699 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,009 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 11,250 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 39,303 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 39,303 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 11,250 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,009 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 11,250 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,009 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 39,303 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 118,755 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 121,613 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-07-30 | 2026-07-30 | 3,847 | $23.38 | $89.9K | 121,338 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 125,185 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-07-30 | 2026-07-30 | 3,847 | $23.38 | $89.9K | 19,912 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 17,329 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,187 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 23,759 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 44,200 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 47,772 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-07-30 | 2026-07-30 | 2,845 | $23.38 | $66.5K | 44,927 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 41,342 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 39,303 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,009 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 11,250 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-07-30 | 2026-07-30 | 2,845 | $23.38 | $66.5K | 44,927 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 47,772 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 44,200 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 41,342 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 39,303 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,009 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 11,250 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-07-30 | 2026-07-30 | 3,847 | $23.38 | $90.0K | 19,912 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 23,759 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,187 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 17,329 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 39,303 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 20,009 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 11,250 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-07-30 | 2026-07-30 | 3,847 | $23.38 | $90.0K | 121,338 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,572 | — | $0 | 125,185 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-07-30 | 2026-07-30 | 2,858 | — | $0 | 121,613 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-07-30 | 2026-07-30 | 3,750 | — | $0 | 118,755 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-02 | 2026-07-02 | 5,221 | — | $0 | 0 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-07-02 | 2026-07-02 | 5,787 | — | $0 | 128,611 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-02 | 2026-07-02 | 5,221 | $1.86 | $9.7K | 18,800 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-07-02 | 2026-07-02 | 5,787 | $8.72 | $50.5K | 24,587 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-07-02 | 2026-07-02 | 11,008 | $23.56 | $259.3K | 13,579 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-06-25 | 2026-06-25 | 15,602 | — | $0 | 134,398 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-06-25 | 2026-06-25 | 13,333 | — | $0 | 0 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-06-25 | 2026-06-25 | 13,333 | $7.26 | $96.8K | 26,912 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-06-25 | 2026-06-25 | 15,602 | $8.72 | $136.0K | 42,514 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-06-25 | 2026-06-25 | 28,935 | $20.06 | $580.4K | 13,579 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-06-25 | 2026-06-25 | 5,394 | $20.00 | $107.9K | 115,005 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-06-02 | 2026-06-02 | 3,422 | — | $0 | 5,221 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-06-02 | 2026-06-02 | 3,422 | $1.86 | $6.4K | 21,727 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-06-02 | 2026-06-02 | 8,148 | $16.60 | $135.3K | 13,579 | SEC↗ |
| GREGORY JULIA P | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| DANSEY ROGER D | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Kapur Anil | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Lacey David L. | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Reinsdorf Judith A | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Saltzman Edward C | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| Silva Paul M | Director | A Award deriv | 2026-05-15 | 2026-05-15 | 31,250 | — | $0 | 31,250 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-05-05 | 2026-05-05 | 13,473 | $16.58 | $223.4K | 38,174 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-05-05 | 2026-05-05 | 582 | $17.18 | $10.0K | 37,592 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-05-04 | 2026-05-04 | 8,148 | $16.96 | $138.2K | 18,305 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-05-01 | 2026-05-01 | 5,394 | $16.76 | $90.4K | 26,453 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 2,000 | — | $0 | 0 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 3,750 | — | $0 | 15,000 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 2,858 | — | $0 | 22,867 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 2,000 | — | $0 | 0 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 2,858 | — | $0 | 22,867 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 3,750 | — | $0 | 15,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 2,000 | — | $0 | 0 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 3,750 | — | $0 | 15,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-04-30 | 2026-04-30 | 2,858 | — | $0 | 22,867 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-04-30 | 2026-04-30 | 3,750 | — | $0 | 120,755 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-04-30 | 2026-04-30 | 2,000 | — | $0 | 117,005 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-04-30 | 2026-04-30 | 2,858 | — | $0 | 123,613 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-04-30 | 2026-04-30 | 3,214 | $16.65 | $53.5K | 120,399 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-04-30 | 2026-04-30 | 3,214 | $16.65 | $53.5K | 31,847 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-04-30 | 2026-04-30 | 2,858 | — | $0 | 35,061 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-04-30 | 2026-04-30 | 3,750 | — | $0 | 32,203 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-04-30 | 2026-04-30 | 2,000 | — | $0 | 28,453 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-04-30 | 2026-04-30 | 3,750 | — | $0 | 51,177 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-04-30 | 2026-04-30 | 2,000 | — | $0 | 47,427 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-04-30 | 2026-04-30 | 2,858 | — | $0 | 54,035 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-04-30 | 2026-04-30 | 2,388 | $16.65 | $39.8K | 51,647 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-04-02 | 2026-04-02 | 8,148 | $15.24 | $124.2K | 26,453 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-03-02 | 2026-03-02 | 8,148 | $15.44 | $125.8K | 34,601 | SEC↗ |
| SANDS ARTHUR T | President, CEO | A Award deriv | 2026-02-10 | 2026-02-10 | 562,500 | — | $0 | 562,500 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | A Award deriv | 2026-02-10 | 2026-02-10 | 93,750 | — | $0 | 93,750 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | A Award deriv | 2026-02-10 | 2026-02-10 | 42,875 | — | $0 | 42,875 | SEC↗ |
| Ring Christine | Chief Legal Officer | A Award deriv | 2026-02-10 | 2026-02-10 | 42,875 | — | $0 | 42,875 | SEC↗ |
| Ring Christine | Chief Legal Officer | A Award deriv | 2026-02-10 | 2026-02-10 | 93,750 | — | $0 | 93,750 | SEC↗ |
| van Houte Hans | Chief Financial Officer | A Award deriv | 2026-02-10 | 2026-02-10 | 93,750 | — | $0 | 93,750 | SEC↗ |
| van Houte Hans | Chief Financial Officer | A Award deriv | 2026-02-10 | 2026-02-10 | 42,875 | — | $0 | 42,875 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-02-09 | 2026-02-09 | 14,261 | $16.66 | $237.6K | 42,749 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-02-03 | 2026-02-03 | 31,333 | — | $0 | 0 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-02-03 | 2026-02-03 | 31,333 | $0.84 | $26.3K | 115,005 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 3,207 | — | $0 | 0 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 3,750 | — | $0 | 18,750 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 2,859 | — | $0 | 25,725 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 1,925 | — | $0 | 0 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 2,859 | — | $0 | 25,725 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 3,750 | — | $0 | 18,750 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 2,859 | — | $0 | 25,725 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 2,000 | — | $0 | 2,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 2,887 | — | $0 | 0 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2026-01-30 | 2026-01-30 | 3,750 | — | $0 | 18,750 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-01-30 | 2026-01-30 | 3,750 | — | $0 | 85,708 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-01-30 | 2026-01-30 | 4,797 | $16.58 | $79.5K | 83,770 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-01-30 | 2026-01-30 | 2,859 | — | $0 | 88,567 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2026-01-30 | 2026-01-30 | 98 | $17.37 | $1.7K | 83,672 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-01-30 | 2026-01-30 | 2,000 | — | $0 | 81,958 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2026-01-30 | 2026-01-30 | 3,207 | — | $0 | 79,958 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-01-30 | 2026-01-30 | 3,750 | — | $0 | 58,572 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-01-30 | 2026-01-30 | 4,333 | $16.58 | $71.8K | 57,098 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-01-30 | 2026-01-30 | 2,859 | — | $0 | 61,431 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-01-30 | 2026-01-30 | 88 | $17.37 | $1.5K | 57,010 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-01-30 | 2026-01-30 | 2,000 | — | $0 | 54,822 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-01-30 | 2026-01-30 | 1,925 | — | $0 | 52,822 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-01-30 | 2026-01-30 | 3,750 | — | $0 | 46,229 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-01-30 | 2026-01-30 | 3,588 | $16.58 | $59.5K | 45,500 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-01-30 | 2026-01-30 | 2,859 | — | $0 | 49,088 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2026-01-30 | 2026-01-30 | 73 | $17.37 | $1.3K | 45,427 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-01-30 | 2026-01-30 | 2,000 | — | $0 | 42,479 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2026-01-30 | 2026-01-30 | 2,887 | — | $0 | 40,479 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2026-01-20 | 2026-01-20 | 3,760 | — | $0 | 8,643 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2026-01-20 | 2026-01-20 | 3,760 | $18.42 | $69.3K | 50,897 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2026-01-20 | 2026-01-20 | 3,760 | $1.86 | $7.0K | 54,657 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-12-18 | 2025-12-18 | 3,760 | — | $0 | 12,403 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-12-18 | 2025-12-18 | 3,760 | $1.86 | $7.0K | 54,657 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2025-12-18 | 2025-12-18 | 200 | $18.56 | $3.7K | 50,897 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2025-12-18 | 2025-12-18 | 3,560 | $17.87 | $63.6K | 51,097 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-11-24 | 2025-11-24 | 37,600 | — | $0 | 16,163 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-11-24 | 2025-11-24 | 37,600 | $1.86 | $69.9K | 88,497 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2025-11-24 | 2025-11-24 | 37,600 | $17.07 | $641.8K | 50,897 | SEC↗ |
| DANSEY ROGER D | Director | A Award deriv | 2025-11-06 | 2025-11-10 | 50,000 | — | $0 | 50,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2025-11-03 | 2025-11-03 | 6,284 | $12.56 | $78.9K | 37,592 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 2,858 | — | $0 | 28,584 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 3,207 | — | $0 | 3,207 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 2,000 | — | $0 | 4,000 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 3,750 | — | $0 | 22,500 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 1,924 | — | $0 | 1,925 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 2,000 | — | $0 | 4,000 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 3,750 | — | $0 | 22,500 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 2,858 | — | $0 | 28,584 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 3,750 | — | $0 | 22,500 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 2,000 | — | $0 | 4,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 2,886 | — | $0 | 2,887 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-10-30 | 2025-10-30 | 2,858 | — | $0 | 28,584 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-10-30 | 2025-10-30 | 2,000 | — | $0 | 74,230 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-10-30 | 2025-10-30 | 3,750 | — | $0 | 77,980 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2025-10-30 | 2025-10-30 | 4,087 | $12.80 | $52.3K | 76,751 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-10-30 | 2025-10-30 | 3,207 | — | $0 | 72,230 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-10-30 | 2025-10-30 | 2,858 | — | $0 | 80,838 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-10-30 | 2025-10-30 | 3,750 | — | $0 | 51,683 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-10-30 | 2025-10-30 | 2,000 | — | $0 | 47,933 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-10-30 | 2025-10-30 | 2,858 | — | $0 | 54,541 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2025-10-30 | 2025-10-30 | 3,644 | $12.80 | $46.6K | 50,897 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-10-30 | 2025-10-30 | 1,924 | — | $0 | 45,933 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-10-30 | 2025-10-30 | 2,886 | — | $0 | 38,398 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-10-30 | 2025-10-30 | 3,750 | — | $0 | 44,148 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-10-30 | 2025-10-30 | 2,858 | — | $0 | 47,006 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2025-10-30 | 2025-10-30 | 3,130 | $12.80 | $40.1K | 43,876 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-10-30 | 2025-10-30 | 2,000 | — | $0 | 40,398 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | A Award deriv | 2025-10-14 | 2025-10-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GREGORY JULIA P | Director | M Exercise deriv | 2025-09-17 | 2025-09-17 | 10,750 | — | $0 | 22,583 | SEC↗ |
| GREGORY JULIA P | Director | M Exercise | 2025-09-17 | 2025-09-17 | 10,750 | $1.86 | $20.0K | 10,750 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2025-08-01 | 2025-08-01 | 5,402 | $11.03 | $59.6K | 35,512 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 2,858 | — | $0 | 31,442 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 3,207 | — | $0 | 6,414 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 3,750 | — | $0 | 26,250 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 2,858 | — | $0 | 31,442 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 1,924 | — | $0 | 3,849 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 2,000 | — | $0 | 6,000 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 3,750 | — | $0 | 26,250 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 2,886 | — | $0 | 5,773 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 2,000 | — | $0 | 6,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 3,750 | — | $0 | 26,250 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-07-30 | 2025-07-30 | 2,858 | — | $0 | 31,442 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2025-07-30 | 2025-07-30 | 4,308 | $12.01 | $51.7K | 69,023 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-07-30 | 2025-07-30 | 3,207 | — | $0 | 64,723 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-07-30 | 2025-07-30 | 2,000 | — | $0 | 66,723 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-07-30 | 2025-07-30 | 3,750 | — | $0 | 70,473 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-07-30 | 2025-07-30 | 2,858 | — | $0 | 73,331 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-07-30 | 2025-07-30 | 2,000 | — | $0 | 41,242 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-07-30 | 2025-07-30 | 1,924 | — | $0 | 39,242 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-07-30 | 2025-07-30 | 3,750 | — | $0 | 44,992 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-07-30 | 2025-07-30 | 2,858 | — | $0 | 47,850 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2025-07-30 | 2025-07-30 | 3,841 | $12.01 | $46.1K | 44,009 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-07-30 | 2025-07-30 | 2,858 | — | $0 | 45,218 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2025-07-30 | 2025-07-30 | 4,304 | $12.01 | $51.7K | 40,914 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-07-30 | 2025-07-30 | 2,886 | — | $0 | 36,610 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-07-30 | 2025-07-30 | 2,000 | — | $0 | 38,610 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-07-30 | 2025-07-30 | 3,750 | — | $0 | 42,360 | SEC↗ |
| Reinsdorf Judith A | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kapur Anil | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Lacey David L. | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Saltzman Edward C | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| GREGORY JULIA P | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Kunkel Lori Anne | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| Silva Paul M | Director | A Award deriv | 2025-05-19 | 2025-05-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2025-05-02 | 2025-05-02 | 6,198 | $11.33 | $70.2K | 33,724 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 2,000 | — | $0 | 8,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 3,750 | — | $0 | 30,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 2,886 | — | $0 | 8,659 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 2,000 | — | $0 | 8,000 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 1,924 | — | $0 | 5,773 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 3,750 | — | $0 | 30,000 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 3,206 | — | $0 | 9,621 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 3,750 | — | $0 | 30,000 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise deriv | 2025-04-30 | 2025-04-30 | 2,000 | — | $0 | 8,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2025-04-30 | 2025-04-30 | 2,438 | $11.50 | $28.0K | 39,922 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-04-30 | 2025-04-30 | 3,750 | — | $0 | 42,360 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-04-30 | 2025-04-30 | 2,886 | — | $0 | 36,610 | SEC↗ |
| van Houte Hans | Chief Financial Officer | M Exercise | 2025-04-30 | 2025-04-30 | 2,000 | — | $0 | 38,610 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-04-30 | 2025-04-30 | 1,924 | — | $0 | 34,462 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-04-30 | 2025-04-30 | 3,750 | — | $0 | 40,212 | SEC↗ |
| Ring Christine | Chief Legal Officer | S Sale | 2025-04-30 | 2025-04-30 | 2,894 | $11.50 | $33.3K | 37,318 | SEC↗ |
| Ring Christine | Chief Legal Officer | M Exercise | 2025-04-30 | 2025-04-30 | 2,000 | — | $0 | 36,462 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-04-30 | 2025-04-30 | 3,206 | — | $0 | 59,143 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-04-30 | 2025-04-30 | 2,000 | — | $0 | 61,143 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | S Sale | 2025-04-30 | 2025-04-30 | 3,377 | $11.50 | $38.8K | 61,516 | SEC↗ |
| Hansen Gwenn | Chief Scientific Officer | M Exercise | 2025-04-30 | 2025-04-30 | 3,750 | — | $0 | 64,893 | SEC↗ |
| Baynes Roy D. | Director | A Award deriv | 2025-03-11 | 2025-03-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| van Houte Hans | Chief Financial Officer | S Sale | 2025-03-03 | 2025-03-03 | 5,125 | $14.40 | $73.8K | 34,424 | SEC↗ |